This page shows the latest leukaemia combo therapy news and features for those working in and with pharma, biotech and healthcare.
Imbruvica paired with Roche’s Gazyva for previously untreated CLL patients. The pairing of of AbbVie’s Imbruvica and Roche’s Gazyva has hit the mark in a chronic lymphocytic leukaemia ... or more) with either CLL or small lymphocytic leukaemia (SLL)
More from news
Approximately 1 fully matching, plus 0 partially matching documents found.
Syneos Health® (Nasdaq:SYNH) is the only fully integrated biopharmaceutical solutions organization. The Company, including a Contract Research Organization (CRO) and...